Patents by Inventor Jerry Bryant

Jerry Bryant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mechanism-Based Targeted Pancreatic Beta Cell Imaging and Therapy
    Publication number: 20100278731
    Abstract: Compositions for imaging pancreatic beta cells comprise chelator-antidiabetic agent conjugates and optionally chelated metals.
    Type: Application
    Filed: November 2, 2009
    Publication date: November 4, 2010
    Inventors: David J. Yang, Chang-Sok Oh, Saady Kohanim, Dong-Fang Yu, Ali Azhdarinia, Jerry Bryant
  • Mechanism-based targeted pancreatic beta cell imaging and therapy
    Patent number: 7611693
    Abstract: Compositions for imaging pancreatic beta cells comprise chelator-antidiabetic agent conjugates and optionally chelated metals.
    Type: Grant
    Filed: September 16, 2004
    Date of Patent: November 3, 2009
    Assignee: Board of Regents, The Univerisity of Texas System
    Inventors: David J. Yang, Chang-Sok Oh, Saady Kohanim, Dong-Fang Yu, Ali Azhdarinia, Jerry Bryant
  • N2S2 chelate-targeting ligand conjugates
    Publication number: 20050129619
    Abstract: The invention provides, in a general sense, a new labeling strategy employing compounds that are are N2S2 chelates conjugated to a targeting ligand, wherein the targeting ligand is a disease cell cycle targeting compound, a tumor angiogenesis targeting ligand, a tumor apoptosis targeting ligand, a disease receptor targeting ligand, amifostine, angiostatin, monoclonal antibody C225, monoclonal antibody CD31, monoclonal antibody CD40, capecitabine, a COX-2 inhibitor, deoxycytidine, fullerene, herceptin, human serum albumin, lactose, leuteinizing hormone, pyridoxal, quinazoline, thalidomide, transferrin, or trimethyl lysine. The present invention also pertains to kits employing the compounds of interest, and methods of assessing the pharmacology of an agent of interest using the present compounds.
    Type: Application
    Filed: December 10, 2003
    Publication date: June 16, 2005
    Inventors: David Yang, Dong-Fang Yu, Chang-Sok Oh, Jerry Bryant
  • Mechanism-based targeted pancreatic beta cell imaging and therapy
    Publication number: 20050100506
    Abstract: Compositions for imaging pancreatic beta cells comprise chelator-antidiabetic agent conjugates and optionally chelated metals.
    Type: Application
    Filed: September 16, 2004
    Publication date: May 12, 2005
    Inventors: David Yang, Chang-Sok Oh, Saady Kohanim, Dong-Fang Yu, Ali Azhdarinia, Jerry Bryant